Search

Displaying results 3261 - 3270 of 4437 in total
  1. Drug

    VTP-201227

    go.drugbank.com/drugs/DB05652
    Experimental

    It is being developed by Vitae Pharmaceuticals.

  2. Drug

    INNO-305

    go.drugbank.com/drugs/DB06025
    Investigational

    INNO-305 is an investigational vaccine developed by Innovive Pharmaceuticals for the treatment of patients with acute myeloid leukemia in complete remission.

  3. Drug

    ONO-2952

    go.drugbank.com/drugs/DB14802
    Investigational

    ONO-2952 is under investigation in clinical trial NCT01887002 (Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable

  4. Drug

    Neutramycin

    go.drugbank.com/drugs/DB20809
    Experimental

    The usage of the INN stem '-mycin' in the name indicates that Neutramycin is a antibiotic, produced by Streptomyces strain. Neutramycin has a monoisotopic molecular weight of 686.35 Da.

  5. Drug

    Heliomycin

    go.drugbank.com/drugs/DB20233
    Experimental

    The usage of the INN stem '-mycin' in the name indicates that Heliomycin is a antibiotic, produced by Streptomyces strain. Heliomycin has a monoisotopic molecular weight of 376.09 Da.

  6. Drug

    Nogalamycin

    go.drugbank.com/drugs/DB20882
    Experimental

    The usage of the INN stem '-mycin' in the name indicates that Nogalamycin is a antibiotic, produced by Streptomyces strain. Nogalamycin has a monoisotopic molecular weight of 787.31 Da.

  7. Drug

    Malathion

    go.drugbank.com/drugs/DB00772
    Approved

    Malathion is a parasympathomimetic organophosphate compound that is used as an insecticide for the treatment of head lice. Malathion is an irreversible cholinesterase inhibitor and has low human toxicity.

  8. Drug

    Salsalate

    go.drugbank.com/drugs/DB01399
    ApprovedInvestigational

    Salsalate is a nonsteroidal anti-inflammatory agent for oral administration. Salsalate's mode of action as an anti-inflammatory and antirheumatic agent may be due to inhibition of synthesis and release of prostaglandins. The usefulness o...

  9. Drug

    RGX-111

    go.drugbank.com/drugs/DB17632
    Investigational

    Developed by REGENXBIO Inc., it was investigated for the treatment of mucopolysaccharidosis Type I (MPS I).[L46666]

  10. Drug

    Sedecamycin

    go.drugbank.com/drugs/DB21342
    Experimental

    The usage of the INN stem '-mycin' in the name indicates that Sedecamycin is a antibiotic, produced by Streptomyces strain. Sedecamycin has a monoisotopic molecular weight of 501.24 Da.